Alera Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$597K Buy
1,852
+116
+7% +$37.9K 0.07% 121
2024
Q2
$542K Buy
1,736
+936
+117% +$275K 0.07% 121
2024
Q1
$227K Buy
+800
New +$234K 0.03% 155
2023
Q2
Sell
-978
Closed -$237K 173
2023
Q1
$237K Sell
978
-200
-17% -$49.1K 0.05% 156
2022
Q4
$309K Sell
1,178
-227
-16% -$60.9K 0.07% 144
2022
Q3
$317K Buy
1,405
+21
+2% +$5.09K 0.09% 138
2022
Q2
$337K Buy
+1,384
New +$339K 0.09% 138
2019
Q2
Sell
-1,361
Closed -$259K 119
2019
Q1
$259K Sell
1,361
-411
-23% -$78.5K 0.13% 59
2018
Q4
$345K Buy
+1,772
New +$346K 0.21% 57

Other funds holding AMGN

Alera Investment Advisors's AMGN Position: Q3 2024 in Review

Alera Investment Advisors increased its Amgen (AMGN) stake by 6.7% in Q3 2024, buying an estimated $37.9K and bringing the position to 1,852 shares worth $597K. The position accounts for 0.07% of the portfolio, ranked #121.

Alera Investment Advisors first reported a position in AMGN in Q4 2018 and has held it in 9 quarters since. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Alera Investment Advisors held 1,852 shares of Amgen worth $597K as of Q3 2024.
  • Alera Investment Advisors bought 116 Amgen shares in Q3 2024, an estimated $37.9K.
  • Amgen made up 0.07% of Alera Investment Advisors's portfolio in Q3 2024, its #121 holding.
  • Alera Investment Advisors first reported a position in Amgen in Q4 2018 and has held it in 9 quarters since.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.